Stock price when the opinion was issued
SJM is a $10B company with a cheap valuation of 10.3X forward earnings, a high yield of 4.6%, but forward earnings growth for FY2026 is expected to decline about 9%. Analyst earnings estimates dropped significantly following its latest results, as it is seeing declining volumes, higher input costs, and it raised prices to protect margins, but consumers are trading down. Due to these concerns, it is expected to see margin compression in the coming year(s). Its valuation has been compressing over the past decade, and for an income investor, we think it is OK and can eventually recover, but we would not be overly interested in the name here.
Unlock Premium - Try 5i Free
Packaged treat business in general is challenged. Aside from tariffs, input costs are rising around the world due to normal inflation over the years. Growth rate's weaker than what he looks for. Only 3.3% earnings growth rate, though PE is cheap at 10x. Below 200-day MA, and moving lower. Value stocks can always get worse.
Showing 25 RSI, indicating oversold. Wait to see if it recovers. If he held it, he wouldn't 6-18 months from now. Nice yield of 4.5%, should be fairly safe.